Blog

How the U.S. Shelved Tariffs on Generic Drugs — A Lifeline for India’s Pharma

White House shelves tariffs on generic drugs, easing pressure on U.S. patients and Indian pharma exports—insight into impact, risks, and strategy. Imagine walking into a pharmacy tomorrow, only to find your essential medications have suddenly skyrocketed in price. For millions of Americans and healthcare systems worldwide, the threat of tariffs on pharmaceutical imports is more […]

Blog

How Google’s $10B Vizag Bet Could Rewire India’s Tech Map

Google plans a $10B data centre cluster in Vizag, India. Explore its impact on jobs, energy, challenges, and India’s tech future (primary keyword: “Google Vizag data center”). Imagine a city waking up one day to the hum of servers, humming pipes for cooling, and the electrified promise of thousands of new engineers, technicians, and support

Blog

Tata Capital IPO Deep Dive — GMP, Listing Chances & Long-Term Outlook

Tata Capital IPO review: price band, GMP, subscription trends, valuation and investor checklist — should you subscribe? Expert view for Indian investors. IPOs are like college reunions — familiar names return with new ambitions, expectations rise, and everyone wonders whether old friendships will pay off. The Tata Capital IPO is precisely that kind of event

Blog

“Titan Q2 FY26 Deep Dive: From Gold Prices to Global Ambitions”

Titan Q2 FY26 results: Titan delivered ~20% YoY growth across consumer businesses. Explore key drivers, segment performance & investor takeaways. Picture this: it’s festival season in India, and jewellery shops are glittering while shoppers decide whether to buy or wait. Suddenly, a trusted brand drops a quarterly update that surprises everyone—Titan just recorded 20% YoY

Scroll to Top